Failure patterns correlate with the tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer
Journal of Surgical Oncology,

Lim SB et al. – More than one–third of patients with locally advanced rectal cancer showed good response to CRT, with improved local and systemic recurrence rates, especially low rates of pulmonary and systemic lymph node recurrence. Recurrence occurred earlier in the GR than the PR group, and oncologic outcomes after recurrence did not differ between the two groups.

  • Response to CRT was evaluated according to tumor regression grade (TRG), with 581 patients categorized into two groups, a good response (GR, TRG 3/4, n=224) and a poor response (PR, TRG 1/2, n=357) group.

  • At a mean follow–up of 61 months, the 5–year overall (88.2% vs. 71.3%, P<0.001) and disease–free (86.7% vs. 63.6%, P<0.001) survival rates were higher in the GR group.
  • In patients with recurrence, time to recurrence was shorter (13.5 months vs. 18.7 months, P=0.01), and the cumulative 2–year recurrence rates (92.9% vs. 73.4%, P=0.024) was higher in the GR group.
  • Rates of local (1.3% vs. 9.5% P<0.001) and systemic (11.6% vs. 27.2%, P<0.001) recurrence were significantly lower in the GR group, as were rates of pulmonary (3.6% vs. 15.1%, P<0.001) and systemic lymph node (1.3% vs. 5.9%, P=0.009) recurrences.
  • The 5–year overall survival rates after recurrence were similar (GR: 23.7% vs. PR: 16.0%, P=0.911).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: A systematic review and meta-analysis of individual patient data The Lancet Oncology, January 14, 2015    Evidence Based Medicine    Review Article

2 Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme Gut, January 6, 2015    Clinical Article

3 The role of the PI3 K pathway in colorectal cancer Critical Reviews in Oncology/Hematology, January 12, 2015    Review Article

4 Diet and physical activity in the prevention of colorectal cancer Journal of the National Comprehensive Cancer Network, December 29, 2014    Clinical Article

5 Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases British Journal of Cancer, January 7, 2015    Clinical Article

6 The clinical and cost effectiveness of aflibercept in combination with irinotecan and fluorouracil-based therapy (FOLFIRI) for the treatment of metastatic colorectal cancer which has progressed following prior oxaliplatin-based chemotherapy: a critique of the evidence PharmacoEconomics, January 29, 2015    Clinical Article

7 Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits International Journal of Colorectal Disease, January 12, 2015    Clinical Article

8 Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases Annals of Surgical Oncology, January 23, 2015    Review Article

9 Recurrence after partial hepatectomy for metastatic colorectal cancer: potentially curative role of salvage repeat resection Annals of Surgical Oncology, January 15, 2015    Clinical Article

10 p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation Full Text World Journal of Gastroenterology, January 13, 2015    Free full text    Review Article

11 Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: A randomized phase III non-inferiority trial Annals of Oncology, January 26, 2015    Clinical Article

12 Clinical significance of thrombocytosis before preoperative chemoradiotherapy in rectal cancer: Predicting pathologic tumor response and oncologic outcome Annals of Surgical Oncology, January 28, 2015    Clinical Article

13 Management of sessile malignant polyps: is colonoscopic polypectomy enough? Surgical Endoscopy, January 13, 2015    Clinical Article

14 Targeted therapies in metastatic colorectal cancer: A systematic review and assessment of currently available data Full Text The Oncologist, November 6, 2014    Free full text    Review Article

15 Role of protective stoma in low anterior resection for rectal cancer: A meta-analysis Full Text World Journal of Gastroenterology, January 2, 2015    Free full text    Evidence Based Medicine

16 Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: A retrospective, population-based study The Lancet Oncology, January 12, 2015    Clinical Article

17 Predictive power of circulating miRNAs in detecting colorectal cancer Tumor Biology, January 9, 2015    Clinical Article

18 Prevalence of advanced colorectal neoplasm after kidney transplantation: surveillance based on the results of screening colonoscopy Digestive Diseases and Sciences, January 14, 2015    Clinical Article

19 Short-term risk of colorectal cancer in individuals with Lynch syndrome: a meta-analysis Journal of Clinical Oncology, January 7, 2015    Evidence Based Medicine    Review Article

20 Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: Final results of the randomized BEBYP trial Annals of Oncology, January 30, 2015    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List